92.83
price down icon1.23%   -1.16
after-market 시간 외 거래: 92.83
loading

Revvity Inc 주식(RVTY)의 최신 뉴스

pulisher
May 02, 2025

UBS Upgrades Revvity (BMV:RVTY) - Nasdaq

May 02, 2025
pulisher
May 02, 2025

UBS Upgrades Revvity (BIT:1RVTY) - Nasdaq

May 02, 2025
pulisher
May 02, 2025

UBS lifts Revvity stock rating to Buy, cuts price target to $115 - Investing.com Australia

May 02, 2025
pulisher
May 02, 2025

UBS Upgrades Revvity (LSE:0KHE) - Nasdaq

May 02, 2025
pulisher
May 01, 2025

UBS Upgrades Revvity (RVTY) - Nasdaq

May 01, 2025
pulisher
May 01, 2025

UBS Boosts Revvity (RVTY) Rating to Buy Amid Growth Prospects | - GuruFocus

May 01, 2025
pulisher
May 01, 2025

UBS lifts Revvity stock rating to Buy, cuts price target to $115 By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook - MSN

May 01, 2025
pulisher
May 01, 2025

UBS Upgrades Revvity to Buy from Neutral, Cuts Price Target to $115 From $145 - marketscreener.com

May 01, 2025
pulisher
Apr 30, 2025

Revvity to Present at Upcoming Investor Conferences | RVTY Stock News - GuruFocus

Apr 30, 2025
pulisher
Apr 30, 2025

KeyBanc Adjusts Revvity's Price Target to $135 From $145 - marketscreener.com

Apr 30, 2025
pulisher
Apr 30, 2025

Revvity CEO and CFO to Share Strategic Vision at BofA and Goldman Sachs Healthcare Conferences - Stock Titan

Apr 30, 2025
pulisher
Apr 30, 2025

Revvity Reports Strong Q1 2025 Financial Results - TipRanks

Apr 30, 2025
pulisher
Apr 29, 2025

Revvity reaffirms 2025 guidance with $4.90-$5 EPS target amid robust software growth - MSN

Apr 29, 2025
pulisher
Apr 29, 2025

Stifel maintains Revvity stock Hold rating, $120 target By Investing.com - Investing.com Canada

Apr 29, 2025
pulisher
Apr 29, 2025

Biotech Firm Revvity Reports Better-Than-Expected Earnings - MSN

Apr 29, 2025
pulisher
Apr 29, 2025

Stifel maintains Revvity stock Hold rating, $120 target - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

Revvity (RVTY) Price Target Adjusted by Baird After Q1 Results | - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Revvity, Inc. (NYSE:RVTY) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 29, 2025
pulisher
Apr 29, 2025

Revvity Exceeds Expectations: Strong Biotech Demand Fuels GrowthNews and Statistics - IndexBox

Apr 29, 2025
pulisher
Apr 29, 2025

Revvity First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance

Apr 29, 2025
pulisher
Apr 29, 2025

Raymond James Adjusts Price Target on Revvity to $120 From $145, Maintains Outperform Rating - marketscreener.com

Apr 29, 2025
pulisher
Apr 29, 2025

Revvity Inc (RVTY) Q1 2025 Earnings Call Highlights: Surpassing Expectations with Strong ... - Yahoo Finance

Apr 29, 2025
pulisher
Apr 29, 2025

Revvity Inc (RVTY) Q1 2025 Earnings Call Highlights: Surpassing Expectations with Strong ... By GuruFocus - Investing.com Canada

Apr 29, 2025
pulisher
Apr 29, 2025

Revvity Inc (RVTY) Q1 2025 Earnings Call Highlights: Surpassing - GuruFocus

Apr 29, 2025
pulisher
Apr 28, 2025

Jefferies Updates Revvity (RVTY) Price Target Amid Market Develo - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity’s Earnings Call: Balanced Growth Amid Challenges - TipRanks

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity (RVTY) Price Target Reduced by Citi to $135, Buy Rating Maintained | RVTY Stock News - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Jefferies Cuts Price Target on Revvity to $106 From $130 - marketscreener.com

Apr 28, 2025
pulisher
Apr 28, 2025

Earnings call transcript: Revvity beats Q1 2025 earnings expectations - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Earnings call transcript: Revvity beats Q1 2025 earnings expectations By Investing.com - Investing.com India

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity: Q1 Earnings Snapshot - The Wilton Bulletin

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity (RVTY) Exceeds Q1 Expectations with Robust Diagnostics G - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up - Nasdaq

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity Q1 2025 slides: 4% organic growth driven by strong Diagnostics performance - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Evercore ISI Adjusts Price Target on Revvity to $116 From $125 - marketscreener.com

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity's Steady Demand Lifts Q1 Results Above Expectations - Finimize

Apr 28, 2025
pulisher
Apr 28, 2025

Earnings Summary: Revvity (RVTY) reports higher revenue and earnings for Q1 2025 - AlphaStreet

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity Q1 Earnings Surpass Street Estimates, Investors Cheer 2025 Revised Revenue Guidance - MSN

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Apr 28, 2025
pulisher
Apr 28, 2025

Life Science Tools Maker Revvity Delivers Strong Q1 Earnings Despite Evolving Macroeconomic Backdrop - Benzinga

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity (RVTY) Surpasses Q1 Estimates and Updates 2025 Outlook - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity Announces Financial Results for the First Quarter of 2025 - Business Wire

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity, Inc. (RVTY) Implements Majority Voting Standard Followi - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity beats quarterly estimates on steady demand for medical equipment - MSN

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity beats Q1 estimates, shares jump 4% - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity Announces Financial Results for the First Quarter of 202 - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity beats Q1 estimates, shares jump 4% By Investing.com - Investing.com Nigeria

Apr 28, 2025
pulisher
Apr 28, 2025

Revvity (RVTY) Exceeds Q1 Revenue Expectations with Strong Perfo - GuruFocus

Apr 28, 2025
diagnostics_research LH
$246.82
price down icon 0.34%
diagnostics_research DGX
$177.57
price down icon 0.21%
diagnostics_research WAT
$348.38
price down icon 0.59%
$157.38
price up icon 0.46%
diagnostics_research MTD
$1,091.13
price down icon 0.81%
diagnostics_research IQV
$152.30
price down icon 0.77%
자본화:     |  볼륨(24시간):